한글목차

에소테릭 검사 시장의 2025년 규모는 320억 9,000만 달러로 추정되고, 2032년에는 678억 9,000만 달러에 이를 것으로 예측되며, 2025-2032년까지의 CAGR은 11.3%를 나타낼 것으로 전망됩니다.

최근의 기술과 의학 연구의 동향으로 고도로 전문화된 진단 검사의 개발이 가능하게 되었기 때문에 에소테릭 검사의 분야는 큰 주목을 받고 있습니다. 에소테릭 검사는 일반적으로 수행되지 않으며 전문 장비, 전문 지식 및 해석이 필요한 임상 검사입니다. 이러한 검사는 희귀질환 진단, 치료 효과 모니터링, 개인화된 건강 관리 솔루션을 제공하는 데 사용됩니다.

세계의 에소테릭 검사 시장은 만성 질환의 유병률 증가, 유전자 검사의 진보, 맞춤형 의료에 대한 수요 증가 등의 요인에 의해 큰 성장을 이루고 있습니다. 에소테릭 검사는 유전자 변이, 바이오마커 및 기타 비정상적인 식별에 중요한 역할을 하며 질병의 조기 발견과 치료에 도움이 됩니다.

시장 역학

세계의 에소테릭 검사 시장은 주로 암, 심혈관 질환, 자가면역 질환 등의 만성 질환의 이환율의 상승에 의해 견인되고 있습니다. 에소테릭 검사는 건강 관리 전문가가 이러한 질병과 관련된 특정 유전자 변이 및 바이오마커를 확인할 수 있게 하여 조기 진단 및 개인화 치료 계획을 촉진합니다. 게다가 정밀의료와 표적요법의 채용이 확대되고 있는 것도 에소테릭 검사 수요를 더욱 밀어 올리고 있습니다.

그러나 에소테릭 검사는 고액인 것, 상환 정책이 불충분하다는 등의 과제에 직면하고 있습니다. 에소테릭 검사는 종종 시행에 필요한 특수 장비 및 전문 지식으로 인해 고액이 됩니다. 게다가 보험업자의 보험적용이 제한되어 있는 것은 특히 개발도상지역에서 이러한 검사의 보급을 방해하고 있습니다.

이러한 과제에도 불구하고 시장에는 성장 기회가 몇 가지 있습니다. 예방 건강 관리에 대한 관심 증가와 질병 조기 발견의 이점에 대한 의식 증가는 에소 테릭 검사 수요를 촉진할 것으로 예측됩니다. 게다가 차세대 시퀀싱과 분자진단과 같은 기술의 진보는 에소텔릭 검사의 정확성과 효율성을 향출시켜 시장 확대의 새로운 길을 열어줄 수 있습니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 에소테릭 검사 시장에 대해 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모나 CAGR 등 상세한 분석을 제공합니다.
• 다양한 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안 매트릭스를 해설했습니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 출시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 본 보고서의 인사이트에 의해 기업의 마케팅 담당자나 경영진은 향후 제품 발매, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있게 됩니다.
• 이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자를 대상으로 합니다.
• 이해관계자는 세계의 에소테릭 검사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
• 만성 질환 및 감염증의 만연
  • 성장 억제요인
• 고액의 비용과 불충분한 상환
  • 기회
• 포인트 오브 케어의 에소테릭 검사
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• PORTER's 분석
• 합병과 인수 시나리오

제4장 세계의 에소테릭 검사 시장 - 코로나 바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 에소테릭 검사 시장 : 유형별(2020-2032년)

• 내분비학
• 종양학
• 분자진단
• 신경학
• 면역학
• 유전자 검사
• 기타

제6장 세계의 에소테릭 검사 시장 : 기술별(2020-2032년)

• 질량 분석
• 실시간 PCR
• 유세포 분석법
• 화학발광
• ELISA
• 방사선 면역 분석
• 기타

제7장 세계의 에소테릭 검사 시장 : 서비스 제공업체별(2020-2032년)

• 독립계 및 참조 연구소
• 병원 기반 연구소
• 전문 클리닉
• 기타

제8장 세계의 에소테릭 검사 시장 : 지역별(2020-2032년)

• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙 아프리카
  • 남아프리카

제9장 경쟁 구도

• LabCorp
• Quest Diagnostics
• OPKO Health
• Miraca Holdings
• Myriad Genetics
• Sonic Healthcare
• Cardio Diagnostics Holdings, Inc
• Veravas
• BPGbio, Inc.
• Fulgent Genetics
• Alveo Technologies, Inc.
• SRL Diagnostics

제10장 섹션

• 조사방법
• 출판사에 대해

영문목차

The Esoteric Testing Market is estimated to be valued at USD 32.09 Bn in 2025 and is expected to reach USD 67.89 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032.

The field of esoteric testing has gained significant attention in recent years, as advancements in technology and medical research have allowed for the development of highly specialized diagnostic tests. Esoteric testing refers to laboratory tests that are not commonly performed and require specialized equipment, expertise, and interpretation. These tests are often used to diagnose rare diseases, monitor treatment effectiveness, and provide personalized healthcare solutions.

The global esoteric testing market is witnessing substantial growth, driven by factors such as the increasing prevalence of chronic diseases, advancements in genetic testing, and the growing demand for personalized medicine. Esoteric testing plays a crucial role in identifying genetic mutations, biomarkers, and other molecular abnormalities that can help in the early detection and treatment of diseases.

Market Dynamics

The global esoteric testing market is primarily driven by the rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders. Esoteric tests enable healthcare professionals to identify specific genetic mutations and biomarkers associated with these diseases, facilitating early diagnosis and personalized treatment plans. Moreover, the growing adoption of precision medicine and targeted therapies further fuels the demand for esoteric testing.

However, the market faces certain challenges, including the high cost of esoteric tests and the lack of reimbursement policies. Esoteric tests are often expensive due to the specialized equipment and expertise required for their execution. Additionally, the limited coverage by insurance providers hinders the widespread adoption of these tests, particularly in developing regions.

Despite these challenges, the market presents several opportunities for growth. The increasing focus on preventive healthcare and the rising awareness about the benefits of early disease detection are expected to drive the demand for esoteric testing. Furthermore, advancements in technology, such as next-generation sequencing and molecular diagnostics, are likely to enhance the accuracy and efficiency of esoteric tests, opening new avenues for market expansion.

Key Features of the Study

• This report provides an in-depth analysis of the global esoteric testing market, including market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, with 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• Key companies covered as a part of this study include LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings, Myriad Genetics, Sonic Healthcare, Cardio Diagnostics Holdings, Inc, Veravas, BPGbio, Inc., Fulgent Genetics, Alveo Technologies, Inc., and S.R.L. Diagnostics
• Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global esoteric testing market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global esoteric testing market

Esoteric Testing Market Segmentation

• By Type
  • Endocrinology
  • Oncology
  • Molecular Diagnostics
  • Neurology
  • Immunology
  • Genetic Testing
  • Others
• By Technology
  • Mass Spectrometry
  • Real Time PCR
  • Flow Cytometry
  • Chemiluminescence
  • ELISA
  • Radioimmunoassay
  • Others
• By Service Provider
  • Independent & Reference Labs
  • Hospital-based Labs
  • Specialty Clinics
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Top Companies in Esoteric Testing Market
  • LabCorp
  • Quest Diagnostics
  • OPKO Health
  • Miraca Holdings
  • Myriad Genetics
  • Sonic Healthcare
  • Cardio Diagnostics Holdings, Inc
  • Veravas
  • BPGbio, Inc.
  • Fulgent Genetics
  • Alveo Technologies, Inc.
  • S.R.L. Diagnostics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Esoteric Testing, By Type
  • Market Esoteric Testing, By Technology
  • Market Esoteric Testing, By Service Provider
  • Market Esoteric Testing, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Rising prevalence of chronic and infectious diseases
  • Restraints
• High costs and inadequate reimbursements
  • Opportunities
• Point-of-care esoteric testing
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Esoteric Testing Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Esoteric Testing Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Molecular Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Immunology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Esoteric Testing Market, By Technology, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Mass Spectrometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Real Time PCR
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Flow Cytometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Chemiluminescence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• ELISA
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Radioimmunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Esoteric Testing Market, By Service Provider, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Independent & Reference Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Hospital-based Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Esoteric Testing Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• LabCorp
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quest Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• OPKO Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Miraca Holdings
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Myriad Genetics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sonic Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cardio Diagnostics Holdings, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Veravas
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BPGbio, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Fulgent Genetics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Alveo Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• S.R.L. Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us